Published in Evid Based Complement Alternat Med on August 04, 2014
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol (2009) 4.63
Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell (2007) 2.51
Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy (2004) 1.58
TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol (2013) 1.20
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
An animal model for screening topical and systemic drugs for potential use in the treatment of psoriasis. J Invest Dermatol (1975) 1.02
Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem (2010) 0.95
Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol (2008) 0.92
Topical drug effects on normal and proliferating epidermal cell models. Arch Dermatol (1981) 0.92
The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol (2003) 0.91
Traditional Chinese medicine is effective and safe in the treatment of psoriasis. Int J Dermatol (2004) 0.89
Tanshinone IIA Inhibits Growth of Keratinocytes through Cell Cycle Arrest and Apoptosis: Underlying Treatment Mechanism of Psoriasis. Evid Based Complement Alternat Med (2011) 0.86
[Qinzhu Liangxue Decoction in treatment of blood-heat type psoriasis vulgaris: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao (2008) 0.85
Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients. J Eur Acad Dermatol Venereol (2011) 0.81
Use of mouse vaginal and rectal epithelium to screen antimitotic effects of systemically administered drugs. Cancer Res (1971) 0.80